iSOFT Adds New Functionality to UK Laboratory Systems

iSOFT Group LimitediSOFT Group Limited, one of the world's largest healthcare IT companies, will release a series of new functions for its i.Laboratory range of pathology solutions and create a UK-based development team to advance the capability of the laboratory business to meet local needs.

The new modules for i.Laboratory will be available ahead of a major user group forum at the International Convention Centre (ICC) in Birmingham on 10-11 June. As well as a platform for demonstrating the new modules, iSOFT will also provide a forum for customers to inform future developments to realise the benefits of current systems.

To ensure iSOFT's UK customers remain at the forefront of laboratory information system technology (LIS), iSOFT has recently created a local development team in the UK. This will grow rapidly to provide a full laboratory development capacity focused on local requirements.

"These significant developments clearly demonstrate our commitment to LIS customers in the UK and Ireland and to growing our market share," said Adrian Stevens, Managing Director of iSOFT’s UK and Ireland business. "The investment in technology and people is a reflection of the importance of the UK LIS market to iSOFT and we will continue to invest to maintain our leadership position.

"The solutions being developed will provide significant new and updated functionality to meet customer needs and ensure they remain at the forefront of laboratory technology," Stevens said. "Our approach means that users can take immediate advantage of powerful new functionality that will begin their journey on to a technology platform designed for the next phase of the evolution of laboratory services in the UK and globally. This means that even as our customers implement discrete functionality to improve business performance in one area or discipline, they will be building the organisation-wide capability to help deliver a laboratory service of the future. The new offerings will help manage information and reduce the time to turnaround test results and will improve the quality of care and cut costs, which is vital in the current economic climate."

Separately iSOFT has also been awarded a contract by NHS Connecting for Health to develop a solution for GPs and other primary care users to request pathology tests and receive results online. The module will work with all major GP systems and is planned for full release in the second half of 2010.

iSOFT has 150 customers in the NHS and Ireland for its laboratory solutions, giving it a 65% share of the market.

The UK development team will create new functions for all i.Laboratory Apex and i.Laboratory TP users, including:

  • GP Test Results Requesting and Reporting
  • Full word processing and digital dictation for cellular pathology
  • Cancer Histopathology Reporting module
  • Dedicated laboratory interface manager
  • Standardised Business Intelligence
  • Infection control
  • Enhanced disease screening - eGFR, stroke risk calculation and CHD risk calculation
  • Cervical cytology
  • New and improved Graphical User Interface
  • Digital solutions for lab-to-lab interconnectivity
  • Configurable dashboards

"With a large installed base in Europe, iSOFT remains one of the continent's largest providers of laboratory information systems," said Gary Cohen, iSOFT's Executive Chairman and CEO. "These and other developments put us in prime position to capitalise on the growth in this sector and deliver solutions at a local and national level to meet the future needs of public and private laboratory services."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...